BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22157397)

  • 1. Cholecystokinin.
    Dockray GJ
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):8-12. PubMed ID: 22157397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vagal afferent pathway does not play a major role in the induction of satiety by intestinal fatty acid in rats.
    Ogawa N; Yamaguchi H; Shimbara T; Toshinai K; Kakutani M; Yonemori F; Nakazato M
    Neurosci Lett; 2008 Mar; 433(1):38-42. PubMed ID: 18248897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin.
    Peters JH; Simasko SM; Ritter RC
    Physiol Behav; 2006 Nov; 89(4):477-85. PubMed ID: 16872644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin and gut-brain signalling.
    Dockray GJ
    Regul Pept; 2009 Jun; 155(1-3):6-10. PubMed ID: 19345244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The versatility of the vagus.
    Dockray GJ
    Physiol Behav; 2009 Jul; 97(5):531-6. PubMed ID: 19419683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents.
    Gourcerol G; Million M; Adelson DW; Wang Y; Wang L; Rivier J; St-Pierre DH; Taché Y
    Peptides; 2006 Nov; 27(11):2811-9. PubMed ID: 16934368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cholecystokinin in the control of food intake.
    Peikin SR
    Gastroenterol Clin North Am; 1989 Dec; 18(4):757-75. PubMed ID: 2693351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGR1 Is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons.
    de Lartigue G; Lur G; Dimaline R; Varro A; Raybould H; Dockray GJ
    Endocrinology; 2010 Aug; 151(8):3589-99. PubMed ID: 20534729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance.
    Dockray GJ; Burdyga G
    Acta Physiol (Oxf); 2011 Mar; 201(3):313-21. PubMed ID: 21062423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Afferent signals regulating food intake.
    Bray GA
    Proc Nutr Soc; 2000 Aug; 59(3):373-84. PubMed ID: 10997653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.
    Gourcerol G; Wang L; Wang YH; Million M; Taché Y
    Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function.
    Whited KL; Thao D; Lloyd KC; Kopin AS; Raybould HE
    Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G156-62. PubMed ID: 16574983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative activation of cultured vagal afferent neurons by leptin and cholecystokinin.
    Peters JH; Karpiel AB; Ritter RC; Simasko SM
    Endocrinology; 2004 Aug; 145(8):3652-7. PubMed ID: 15105382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cholecystokinin (CCK 1) and serotonin (5-HT 3) receptors increases the discharge of pancreatic vagal afferents.
    Mussa BM; Sartor DM; Verberne AJ
    Eur J Pharmacol; 2008 Dec; 601(1-3):198-206. PubMed ID: 19026634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine control of food intake.
    Valassi E; Scacchi M; Cavagnini F
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensory signal transduction in the vagal primary afferent neurons.
    Li Y
    Curr Med Chem; 2007; 14(24):2554-63. PubMed ID: 17979708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans.
    Burdyga G; Lal S; Spiller D; Jiang W; Thompson D; Attwood S; Saeed S; Grundy D; Varro A; Dimaline R; Dockray GJ
    Gastroenterology; 2003 Jan; 124(1):129-39. PubMed ID: 12512037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric effects of cholecystokinin and its interaction with leptin on brainstem neuronal activity in neonatal rats.
    Yuan CS; Attele AS; Dey L; Xie JT
    J Pharmacol Exp Ther; 2000 Oct; 295(1):177-82. PubMed ID: 10991976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin/Cholecystokinin-1 receptor-mediated peripheral activation of the afferent vagus by enteral nutrients attenuates inflammation in rats.
    Lubbers T; de Haan JJ; Luyer MD; Verbaeys I; Hadfoune M; Dejong CH; Buurman WA; Greve JW
    Ann Surg; 2010 Aug; 252(2):376-82. PubMed ID: 20585240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats.
    de Lartigue G; Barbier de la Serre C; Espero E; Lee J; Raybould HE
    PLoS One; 2012; 7(3):e32967. PubMed ID: 22412960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.